Immunic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
CEODaniel Vitt
CEODaniel Vitt
Employees91
Employees91
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2003
Founded2003
Employees91
Employees91
IMUX Key Statistics
Market cap74.65M
Market cap74.65M
Price-Earnings ratio-0.72
Price-Earnings ratio-0.72
Dividend yield—
Dividend yield—
Average volume1.29M
Average volume1.29M
High today$0.678
High today$0.678
Low today$0.61
Low today$0.61
Open price$0.6703
Open price$0.6703
Volume1.72M
Volume1.72M
52 Week high$1.39
52 Week high$1.39
52 Week low$0.561
52 Week low$0.561
Stock Snapshot
Immunic(IMUX) stock is priced at $0.61, giving the company a market capitalization of 74.65M. It carries a P/E multiple of -0.72.
As of 2025-12-13, Immunic(IMUX) stock has fluctuated between $0.61 and $0.68. The current price stands at $0.61, placing the stock 0.0% above today's low and -10.0% off the high.
Immunic(IMUX) shares are trading with a volume of 1.72M, against a daily average of 1.29M.
During the past year, Immunic(IMUX) stock moved between $0.56 at its lowest and $1.39 at its peak.
During the past year, Immunic(IMUX) stock moved between $0.56 at its lowest and $1.39 at its peak.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own IMUX. This list is generated using Robinhood data, and it’s not a recommendation.